Please login to the form below
CALD gene therapy
This page shows the latest CALD gene therapy news and features for those working in and with pharma, biotech and healthcare.
Bluebird bags breakthrough status for CALD gene therapy
News comes after impressive data from a phase II/III trial. Bluebird Bio has claimed an FDA breakthrough designation for its Lenti-D gene therapy for cerebral adrenoleukodystrophy (CALD) – a rare ... Bluebird’s gene therapy approach could do away
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
- Freelance Senior Account Manager / Account Director - Healthcare...
-
£350-400 depending on experience
-
Digital Account Director
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Scientific Director – Medical Communications
-
Salary TBC
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Account Director, Medical Education
-
Salary TBC
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Freelance AM/ AD Healthcare Advertising
-
£350-400 depending on experience
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Health Consultant - Brand Comms
-
Competitive Salary
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior Account Manager, Medical Communications, London
-
Excellent package
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
Subscribe to our email news alerts
- Brain power: fresh approaches to Alzheimer’s drug discovery
- Roche, AbbVie hit by clinical hold for Venclexta in myeloma
- BMS defends Celgene buyout ahead of shareholder vote
- Apple Watch shows promise in heart study, but doctors sceptical
- Is May’s Brexit deal sinking after Speaker's procedural torpedo?
- Roche gets FDA nod for Tecentriq in small cell lung cancer
PMHub
M3 (EU)
M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...
Latest intelligence
- Brain power: fresh approaches to Alzheimer’s drug discovery
- New alliances are learning from past mistakes and breaking down research barriers...
- Genomics integration: can the NHS rise to the challenge?
- Experts gather to discuss the UK’s genomic landscape...
- “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
- The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
Quick links
Infographics
